$0.54
+0.02 (+4.04%)
Open$0.52
Previous Close$0.52
Day High$0.55
Day Low$0.51
52W High$52.16
52W Low$30.67
Volume—
Avg Volume272.5K
Market Cap38.56M
P/E Ratio46.19
EPS$0.84
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+9,132.8% upside
Current
$0.54
$0.54
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.59M | 12.91M | 9.78M |
| Net Income | -1,338,243 | -1,683,285 | -1,199,258 |
| Profit Margin | -10.6% | -13.0% | -12.3% |
| EBITDA | -1,969,871 | -1,762,148 | -1,377,431 |
| Free Cash Flow | -1,414,748 | -1,276,245 | -1,101,740 |
| Rev Growth | -1.9% | -7.4% | -8.7% |
| Debt/Equity | 1.05 | 0.93 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |